Adult botulism type F in the United States, 1981-2002
- PMID: 16344510
- DOI: 10.1212/01.wnl.0000187127.92446.4c
Adult botulism type F in the United States, 1981-2002
Abstract
Background: Clostridium botulinum neurotoxin types A, B, and E cause most cases of the paralytic disease botulism. Little is known about the epidemiology, clinical features, or microbiology of botulism type F.
Methods: Cases of adult type F botulism were identified by review of data collected by CDC's National Botulism Surveillance System between 1981 and 2002. A case was either an individual whose serum or stool demonstrated type F toxin or whose stool culture yielded an organism producing toxin type F. A detailed review of cases' medical charts and laboratory data from CDC and local health departments was performed.
Results: Between 1981 and 2002, 1,269 cases of botulism among adults and infants were reported to CDC; 13 (1%) were adult type F. The median age of type F cases was 54 years; 7 (54%) were female. None were part of outbreaks. A toxigenic Clostridium baratii was identified in 9 (69%) of 13 cases. Among 11 cases for which clinical data were available, all required mechanical ventilation for a median duration of 17 days (range, 10 to 84); 8 (73%) were intubated within 24 hours of symptom onset. All patients had nearly complete or complete quadriplegia at the nadir of neurologic dysfunction, which occurred on average on day 5. On average by day 8, improvement in neuromuscular function was noted. The median duration of acute hospitalization was 31 days (range, 20 to 60). No deaths were reported. In only one case was a possible foodborne etiology identified.
Conclusions: Toxigenic C baratii are the sole documented causes of type F botulism in the United States since 1981. These cases are characterized by a fulminant course with rapid progression to respiratory failure and paralysis, making early recognition and intervention critical to appropriate management.
Similar articles
-
Infant botulism, type F, presenting at 54 hours of life.Pediatr Neurol. 2005 Mar;32(3):193-6. doi: 10.1016/j.pediatrneurol.2004.09.003. Pediatr Neurol. 2005. PMID: 15730901
-
A cluster of three cases of botulism due to Clostridium baratii type F, France, August 2015.Euro Surveill. 2016;21(4). doi: 10.2807/1560-7917.ES.2016.21.4.30117. Euro Surveill. 2016. PMID: 26848055
-
Long-term outcomes of 217 botulism cases in the Republic of Georgia.Clin Infect Dis. 2007 Jul 15;45(2):174-80. doi: 10.1086/518890. Epub 2007 Jun 5. Clin Infect Dis. 2007. PMID: 17578775
-
Botulism: the challenge of diagnosis and treatment.Rev Neurol Dis. 2006 Fall;3(4):182-9. Rev Neurol Dis. 2006. PMID: 17224901 Review.
-
Infant botulism.Am Fam Physician. 2002 Apr 1;65(7):1388-92. Am Fam Physician. 2002. PMID: 11996423 Review.
Cited by
-
Structural Basis of Botulinum Toxin Type F Binding to Glycosylated Human SV2A: In Silico Studies at the Periphery of a Lipid Raft.Biomolecules. 2022 Dec 6;12(12):1821. doi: 10.3390/biom12121821. Biomolecules. 2022. PMID: 36551250 Free PMC article.
-
Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021.MMWR Recomm Rep. 2021 May 7;70(2):1-30. doi: 10.15585/mmwr.rr7002a1. MMWR Recomm Rep. 2021. PMID: 33956777 Free PMC article.
-
Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model.Toxins (Basel). 2019 Apr 6;11(4):208. doi: 10.3390/toxins11040208. Toxins (Basel). 2019. PMID: 30959899 Free PMC article.
-
Asymmetric type F botulism with cranial nerve demyelination.Emerg Infect Dis. 2012 Jan;18(1):102-4. doi: 10.3201/eid1801.110471. Emerg Infect Dis. 2012. PMID: 22257488 Free PMC article.
-
Two simultaneous botulism outbreaks in Barcelona: Clostridium baratii and Clostridium botulinum.Epidemiol Infect. 2013 Sep;141(9):1993-5. doi: 10.1017/S0950268812002592. Epub 2012 Nov 19. Epidemiol Infect. 2013. PMID: 23158693 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical